Shirley das Graças Ferreira
Research Subjects
Shirley das Graças Ferreira has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Henrique Lima Couto
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
3 shared publications - Tereza Cristina de Oliveira Ferreira
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
3 shared publications - Aleida Nazareth Soares
Santa Casa Faculty of Health Sciences, Belo Horizonte, Brazil
2 shared publications - Amanda Cristina Braga de Oliveira
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
2 shared publications - Ana Carolina Guglielmelli Mendonça
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
2 shared publications - André Mattar
Women Hospital, São Paulo, Brazil
2 shared publications
Latest Publications
- 28 September 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 11000-11001
ASO Visual Abstract: Cavity Margins Sample Shaving Evaluation as Part of Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Breast Cancer Excision
- 28 September 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 11000-11001
ASO Visual Abstract: Cavity Margins Sample Shaving Evaluation as Part of Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Breast Cancer Excision
- Open Access
- 28 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10918-10929
Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision
Background: Excision of small breast cancers has been reported by vacuum-assisted biopsy (VAB). Nevertheless, patients are submitted to surgery, because there is no way to predict excision. The purpose of this study was to evaluate extended vacuum-assisted biopsy (EVAB) associated with cavity margins sample shaving (CMSH) to predict breast cancer excision. Methods: This is a retrospective database analysis of 120 cancers [both invasive breast cancers (IC) and ductal carcinoma in situ (DCIS)] diagnosed by EVAB-CMSH submitted to surgery with histological data from EVAB-CMSH and surgery. The CMSH was evaluated as a diagnostic test for excision compared to surgery as gold standard. Factors associated with residual tumor, gross residual tumor (GRD) (> 3 mm), and false-negative CMSH after EVAB-CMSH were evaluated. Results: A total of 120 cases were analyzed. Media age was 57 (48.5–69); image tumor size ( T ) was 11 (8.6–15) mm; pathological tumor size (pT) was 6 (4–10) mm; most cases IC+DCIS 53 (44.2%), DCIS 46 (38.3%), and IC 15 (12.5%); 45 (37.5%) were excised by EVAB-CMSH. CMSH sensitivity 70.7%, specificity 66.7%, false-negative rate 18.33%, and accuracy 69.2%. In multivariate analysis, DCIS pT ( p = 0.003, odds ratio [OR] 1.46, 95% confidence interval [CI]) was associated with residual tumor; DCIS pT ( p = 0.001, OR 1.34, 95% CI) and the CMSH T ( p = 0.001, OR 1.67, 95% CI) with GRD; surgical specimen DCIS T ( p = 0.015, OR 1.12, 95% CI) with CMSH false negative. Conclusions: Cavity margins sample shaving is a potential approach to predict small breast cancer excision and should be added to vacuum-assisted excision in prospective trials. For DCIS, EVAB-CMSH should not be standard of care.
- 28 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10918-10929
Open AccessCavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision
Background: Excision of small breast cancers has been reported by vacuum-assisted biopsy (VAB). Nevertheless, patients are submitted to surgery, because there is no way to predict excision. The purpose of this study was to evaluate extended vacuum-assisted biopsy (EVAB) associated with cavity margins sample shaving (CMSH) to predict breast cancer excision. Methods: This is a retrospective database analysis of 120 cancers [both invasive breast cancers (IC) and ductal carcinoma in situ (DCIS)] diagnosed by EVAB-CMSH submitted to surgery with histological data from EVAB-CMSH and surgery. The CMSH was evaluated as a diagnostic test for excision compared to surgery as gold standard. Factors associated with residual tumor, gross residual tumor (GRD) (> 3 mm), and false-negative CMSH after EVAB-CMSH were evaluated. Results: A total of 120 cases were analyzed. Media age was 57 (48.5–69); image tumor size ( T ) was 11 (8.6–15) mm; pathological tumor size (pT) was 6 (4–10) mm; most cases IC+DCIS 53 (44.2%), DCIS 46 (38.3%), and IC 15 (12.5%); 45 (37.5%) were excised by EVAB-CMSH. CMSH sensitivity 70.7%, specificity 66.7%, false-negative rate 18.33%, and accuracy 69.2%. In multivariate analysis, DCIS pT ( p = 0.003, odds ratio [OR] 1.46, 95% confidence interval [CI]) was associated with residual tumor; DCIS pT ( p = 0.001, OR 1.34, 95% CI) and the CMSH T ( p = 0.001, OR 1.67, 95% CI) with GRD; surgical specimen DCIS T ( p = 0.015, OR 1.12, 95% CI) with CMSH false negative. Conclusions: Cavity margins sample shaving is a potential approach to predict small breast cancer excision and should be added to vacuum-assisted excision in prospective trials. For DCIS, EVAB-CMSH should not be standard of care.
Minimally invasive treatment of gynecomastia by ultrasound-guided vacuum-assisted excision: report of a case series
Introduction: Gynecomastia (GM) is a benign proliferation of glandular breast tissue in men. Some cases need surgical intervention. Traditional open surgery by semicircular inferior periareolar incision is the most common surgical approach. In order to obtain better esthetic results, some alternatives to open surgery have been proposed, such as liposuction, endoscopic mastectomy, and vacuum-assisted excision (VAE). Objective: To describe the technical surgical approach of ultrasound-guided VAE of GM and its results from a case series. Method: This is an evaluation of seven GM cases submitted to ultrasound-guided VAE with a 10G needle using the ENCOR® BD whole circumference automated breast biopsy system in Redimasto – Redimama, a Brazilian breast center. The result was considered good or satisfactory when it showed minimal remaining gland, good symmetry, no retraction, necrosis, hypertrophic scar, or displacement of the nipple-areola complex. All patients answered a questionnaire to evaluate their satisfaction and perception of the procedure. Results: Seven (7) patients with Simon grade 1 and 2 bilateral GM underwent ultrasound-guided VAE. No case of displacement, necrosis, or retraction of the nipple-areola complex, post-procedure bleeding, infection, skin necrosis, or asymmetry was detected. No patient reported decrease or change in nipple sensation or erection. All patients had bruises and hematomas that spontaneously resolved within 30 days. All results were considered good or excellent by patients and surgeons. Conclusion: Minimally invasive ultrasound-guided VAE is an excellent alternative for the treatment of GM. It is better indicated for Simon grade 1 and 2 GM, with good and excellent esthetic results, small scar, and low rates of nipple and areolar complications. It allows an outpatient procedure with low morbidity (local anesthesia) and fast recovery.
Minimally invasive treatment of gynecomastia by ultrasound-guided vacuum-assisted excision: report of a case series
Introduction: Gynecomastia (GM) is a benign proliferation of glandular breast tissue in men. Some cases need surgical intervention. Traditional open surgery by semicircular inferior periareolar incision is the most common surgical approach. In order to obtain better esthetic results, some alternatives to open surgery have been proposed, such as liposuction, endoscopic mastectomy, and vacuum-assisted excision (VAE). Objective: To describe the technical surgical approach of ultrasound-guided VAE of GM and its results from a case series. Method: This is an evaluation of seven GM cases submitted to ultrasound-guided VAE with a 10G needle using the ENCOR® BD whole circumference automated breast biopsy system in Redimasto – Redimama, a Brazilian breast center. The result was considered good or satisfactory when it showed minimal remaining gland, good symmetry, no retraction, necrosis, hypertrophic scar, or displacement of the nipple-areola complex. All patients answered a questionnaire to evaluate their satisfaction and perception of the procedure. Results: Seven (7) patients with Simon grade 1 and 2 bilateral GM underwent ultrasound-guided VAE. No case of displacement, necrosis, or retraction of the nipple-areola complex, post-procedure bleeding, infection, skin necrosis, or asymmetry was detected. No patient reported decrease or change in nipple sensation or erection. All patients had bruises and hematomas that spontaneously resolved within 30 days. All results were considered good or excellent by patients and surgeons. Conclusion: Minimally invasive ultrasound-guided VAE is an excellent alternative for the treatment of GM. It is better indicated for Simon grade 1 and 2 GM, with good and excellent esthetic results, small scar, and low rates of nipple and areolar complications. It allows an outpatient procedure with low morbidity (local anesthesia) and fast recovery.